delete Health Insurance (Pathology Services Table) Amendment Regulation 2012 (No. 1)
Amends the Pathology Services Table under the Health Insurance Act 1973, modifying Medicare Benefits Schedule (MBS) items for pathology services including item descriptions, fees, and claiming conditions. Regulates what pathology tests can be claimed, at what price, and under what circumstances.
This instrument exemplifies price controls and centralized rationing of healthcare services. By fixing fees and conditions for pathology services, it distorts market signals, reduces supply responsiveness, creates compliance costs for pathology providers, and rations services through bureaucratic determination rather than consumer choice. Pathology services in Australia have become heavily concentrated among a few large players partly due to these regulatory barriers to entry and price controls, reducing competition and innovation. The unintended consequences include limited access to newer/better tests not on the schedule, reduced incentive for efficiency, and barriers for smaller players to compete. Australians would be better served by a system where pathology pricing reflects market dynamics and consumer preferences rather than regulatory fiat.